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In a prospective study of 10011 men with 815 prostate cancer cases, despite plausible biological mechanisms, neither increasing
intake levels of dairy products nor calcium from dairy products (P trend; 0.23 and 0.64, respectively), or calcium supplements was
associated with prostate cancer risk (relative risk, 1.05; 95% confidence interval, 0.84–1.31).
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Prostate cancer is the most commonly diagnosed non-skin cancer
among men in North America, Europe, and parts of Africa, with
the United States having the highest prostate cancer incidence in
the world (Gronberg, 2003). Although its incidence is increasing
steadily in almost all countries, few modifiable predictors for the
disease have been identified (Gronberg, 2003). Well-established
risk factors, such as age, family history, race, and country of
residence, are not amenable to modification and have limited
utility as primary prevention strategies.
Calcium intake, a modifiable dietary factor, has recently been
proposed as a risk factor for prostate cancer. Evidence from in
vitro and animal studies suggests that risk may be increased by
higher levels of calcium, since these suppress 1,25-dihydroxy-
vitamin D3, the most active form of vitamin D3, that inhibits the
proliferation of prostate cancer cells and promotes their differ-
entiation (Schwartz et al, 1995, 1997; Giovannucci, 1998). However,
relevant studies have yielded inconsistent results (Gao et al, 2005),
although few studies have considered intake from calcium
supplementation, that can provide higher doses than dietary
intake. Given calcium’s importance in the prevention of diseases
such as osteoporosis, we conducted a study of the question in a
large cohort of men.
MATERIALS AND METHODS
Subjects
The Harvard Alumni Health Study, initiated in the 1960s, is an
ongoing cohort study of men who entered Harvard University,
United States, as undergraduates between 1916 and 1950. Health
information is obtained from subjects via questionnaires mailed at
periodic intervals. The present study utilises data from a
questionnaire mailed in 1988 that included detailed information
on diet, and eligible subjects were 12805 men who responded. We
excluded men reporting cancer at baseline (n¼1731) and those
not providing information on dairy product intake (n¼60). Of the
remaining 11014 men, we successfully followed 10011 (90.9%) for
the development of prostate cancer; these men represent the
subjects for the present analysis.
Assessment of calcium intake and other factors
The 1988 questionnaire assessed diet using an abbreviated
version (23 food items) of a validated semiquantitative food
frequency questionnaire (Willett et al, 1985, 1987). Men indicated
their usual daily intake of seven different dairy products (whole
milk, low fat milk, cream, ice cream, yogurt, cheese and butter)
using pre- specified responses ranging from ‘almost never’ to ‘six
or more times per day.’ On the original, longer version of the
questionnaire, 13 dairy items were assessed. However, we believe
our assessment of calcium intake using the seven items s
reasonably valid. While we did not directly validate our 7-item
questionnaire against the longer questionnaire, a previous study
that assessed fewer items – milk (including whole, skim and milk
with cereal), cheese and ice cream – was able to account for 82% of
the variation in calcium consumption in male physicians (Chan
et al, 2001).
We estimated calcium intake in mgday
 1 based on the
frequency of consumption of each dairy product and the calcium
composition of specified portions of each dairy product, using data
from the US Department of Agriculture (US). In addition to dairy
products, we asked alumni about use of calcium supplements
(occasional use, use of ordinary daily dose, or use of high daily
dose).
From the 1988 questionnaire, we also obtained information on
potential confounders, including weight, height, physical activity,
cigarette smoking, alcohol intake, and paternal history of prostate
cancer.
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Men reported physician-diagnosed prostate cancer on subsequent
health questionnaires in 1993 and 1998. A previous validation
study has shown that such self-reports were confirmed by
attending physicians in 91% of cases (Lee et al, 1992). In addition,
we obtained death certificates for men who died through 1998 to
ascertain cases of fatal prostate cancer.
Data analyses
In separate analyses, we considered intakes of (1) dairy products,
(2) calcium from dairy products, and (3) calcium supplements, in
relation to prostate cancer risk. For dairy products, we created
a dairy score, representing servings of dairy products per day,
by summing the frequency of consumption of the seven dairy
products, and categorised men into approximate quartiles
(Table 1). Similarly, we grouped men into approximate quartiles
of calcium intake, in mgday
 1, based on the frequency of
consumption of each dairy product and the calcium composition
of each dairy product (Table 2). For supplements, because only 8%
of men reported using supplemental calcium (with most taking an
ordinary daily dose), we grouped men as non-users or users. We
used Cox proportional hazards regression models to estimate the
relative risks (RR) and 95% confidence intervals for developing
prostate cancer associated with dairy and calcium intakes. Initially,
we adjusted for age (in continuous years) only, but later for the
following potential confounders: body mass index (o22.5, 22.5–
o25.0, 25.0–o27.5, or X27.5kgm
 2), physical activity (o1000,
1000–2499, or X2500kcalweek
 1), smoking (never, past, or
current), total energy intake (in quartiles), alcohol intake (none,
1–3, 4–6, or Xseven drinksweek
 1), red meat intake (pthree
servingsmonth, 1–2 servingsweek, or Xthree servingsweek
 1),
vegetable intake (psix servingsweek, 1–2 servingsday, or Xthree
servingsday
 1), and paternal history of prostate cancer (no or
yes). We repeated the above analyses, examining only fatal
prostate cancer, owing to the suggestion from some previous
studies that the association may be stronger with advanced or fatal
prostate cancer (Giovannucci et al, 1998; Schuurman et al, 1999;
Chan et al, 2001; Rodriguez et al, 2003).
RESULTS
Among the 10011 men, the mean age at baseline in 1988 was 67
years. Table 1 shows the baseline characteristics of subjects
according to dairy product intake. Men in the highest quartile of
dairy consumption tended to be older, were more likely to smoke,
and were less likely to be overweight. They also consumed more
red meat and vegetables, and were more likely to have a paternal
history of prostate cancer. There were no clear trends for physical
activity and alcohol consumption.
During follow-up through 1998, 815 incident cases of prostate
cancer developed, of which 99 cases were fatal. Table 2 shows no
significant relation between higher intakes of dairy products and
risk of prostate cancer, whether in age- or multivariate-adjusted
analyses (P trend¼0.16 and 0.23, respectively). In multivariate
analyses, men in the highest quartile had an RR of prostate cancer
of 1.11 (95% confidence interval, 0.85–1.46), compared with the
lowest quartile. When individual dairy products were examined,
there were also no significant associations (data not shown).
For calcium intake, Table 2 shows that levels of intake were not
significantly associated with prostate cancer risk, either in age- or
multivariate-adjusted analyses (P trend¼0.93 and 0.64, respec-
tively). Calcium supplement use was also not significantly related
to risk (multivariate RR¼1.05 (0.84–1.31)).
When we repeated the above analyses, examining only fatal
(instead of all) prostate cancer, we continued to observe no
significant associations between dairy product or calcium intakes
and risk of fatal prostate cancer (P trend¼0.64 and 0.52,
respectively; Table 3).
DISCUSSION
This large study does not support the hypothesis that higher
intakes of calcium are associated with an increased risk of prostate
Table 1 Baseline characteristics of men in 1988 according to dairy product intake, Harvard Alumni Health Study
Dairy product intake (servings/day)
a
Characteristic 0–o1.25 (n¼2460) 1.25–o2.00 (n¼2537) 2.00–o3.25 (n¼2416) X3.25 (n¼2598)
Mean age (s.d.) (years) 66.0 (7.5) 66.9 (7.9) 67.3 (8.0) 68.7 (8.4)
Cigarette smoking (%) 7.6 7.6 6.7 10.1
Overweight or obese (%)
a 46.0 43.4 42.6 39.4
Physical activity X1000 kcal/week (%)
b 67.3 70.2 69.3 66.2
Alcohol intake (%) 71.4 73.0 73.7 70.4
Red meat intake X3 servings/week (%) 21.2 25.3 33.4 38.7
Vegetable intake X3 servings/day (%) 14.2 12.6 13.7 18.6
Paternal history of prostate cancer (%) 3.2 3.5 4.8 4.2
aBody mass index X25kgm
 2.
bSufficient to meet recommended level of physical activity.
Table 2 RR of total prostate cancer according to dairy product and
calcium intake, Harvard Alumni Health Study
Age-adjusted
RR (95%
confidence
interval)
Multivariate
RR
a (95%
confidence
interval)
Dairy product intake (servings/day)
b
0–o1.25 (189 cases) 1.00 (referent) 1.00 (referent)
1.25–o2.00 (183 cases) 0.91 (0.74–1.12) 0.91 (0.71–1.15)
2.00–o3.25 (220 cases) 1.14 (0.90–1.39) 1.11 (0.87–1.42)
X3.25 (223 cases) 1.07 (0.88–1.31) 1.11 (0.85–1.46)
P trend¼0.16 P trend¼0.23
Dairy calcium intake (mg/day)
b
0–199 (209 cases) 1.00 (referent) 1.00 (referent)
200–449 (167 cases) 0.83 (0.68–1.02) 0.81 (0.64–1.02)
450–599 (238 cases) 0.97 (0.81–1.17) 0.91 (0.73–1.14)
X600
c (201 cases) 0.96 (0.79–1.17) 0.91 (0.70–1.18)
P trend¼0.93 P trend¼0.64
RR¼relative risks.
aAdjusted for age; smoking; body mass index; physical activity;
intakes of alcohol, red meat and vegetables; total caloric intake; and paternal history
of prostate cancer.
bSummed from intakes of milk, low-fat milk, cream, yogurt, cheese,
ice cream, and butter.
cMedian 849mgday
 1; interquartile range 710–
1416mgday
 1.
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intake of dairy products, dairy calcium, or calcium supplements
and risk of either all or fatal prostate cancer. It is important to
clarify the subject because calcium intake clearly is beneficial
for other diseases, such as osteoporosis (Prentice, 2002). The UK
Department of Health recommends that adults consume
700mgday
 1 of calcium (Prentice, 2002); in the United States,
the Institute of Medicine recommends 1000–1200mgday
 1
(Prentice, 2002).
Although we did not observe any significant associations, it
appears biologically plausible for higher calcium intakes to
increase prostate cancer risk. High circulating levels of calcium
suppress 1,25-dihydroxyvitamin D3, the most active form of
vitamin D. In vitro, 1,25-dihydroxyvitamin D3 inhibits the growth
of cancerous prostate epithelial cells and promotes their differ-
entiation (Schwartz et al, 1995, 1997; Giovannucci, 1998). Animal
studies also have shown that administration of 1,25-dihydroxy-
vitamin D3 or its analogues reduces the growth of prostate gland
tumours (Lucia et al, 1995). Additionally, higher intakes of milk
and calcium may increase insulin-like growth factor-1 (IGF-1)
(Gunnell et al, 2003), which may be associated with increased
prostate cancer risk (Renehan et al, 2004).
Findings from previous studies have been conflicting. While
some large cohort studies (with 4500 cases) have reported
significant positive associations between dairy products and/or
calcium intake and risk (Giovannucci et al, 1998; Chan et al, 2001),
others have not (Schuurman et al, 1999; Michaud et al, 2001;
Rodriguez et al, 2003). A recent clinical trial of calcium
supplementation (1200mgday
 1) in the prevention of colorectal
adenomas found no significant increase in prostate cancer (70
cases) risk with supplementation in secondary analyses, and even a
suggestion of a protective effect (Baron et al, 2005). A 2005 meta-
analysis of prospective cohort studies reported increased RR of
1.11 (95% confidence interval, 1.00–1.22) and 1.39 (1.09–1.77) for
all prostate cancer among men with the highest intakes of dairy
products and calcium, respectively, and stronger associations for
advanced prostate cancers (RR¼1.33 and 1.46, respectively) (Gao
et al, 2005). However, with the inclusion of a 2006 Australian study
that found no association with calcium intake (Severi et al, 2006),
the findings for all prostate cancer were weakened (RR¼1.09
(1.00–1.20) for dairy products; 1.32 (1.05–1.67) for calcium)
(Severi et al, 2006). The present study agrees with the Australian
data, in showing no significant relation between calcium intake
and risk.
Strengths of the present study include its prospective design,
large number of cases (including fatal cases), and high rates of
follow-up. Additionally, dietary information was ascertained using
a validated food frequency questionnaire, and information was
available on several potential confounders. The study also included
many older men (baseline age 67 years), who are at greater risk for
prostate cancer (Gronberg, 2003).
One potential limitation is that the calcium intake may have
been too low in the present study. The highest category of calcium
intake from dairy products was X600mgday
 1 (median
849mgday
 1; interquartile range 710–1416mgday
 1). Thus,
many men would have had intakes below US recommendations,
and several would have had intakes falling below UK recommen-
dations (Prentice, 2002). However, a previous large study did
observe a significantly increased risk at X600mgday
 1 calcium
intake (Chan et al, 2001), making it less likely that the range of
intakes was responsible for our null findings. Further, since we
relied on self-reported diet, random misclassification may have
occurred, biasing findings to the null. However, the large number
of cases offers some assurance that an association of moderate
magnitude, as has been reported in previous studies (Giovannucci
et al, 1998), would not have been missed. Finally, we were
specifically interested in advanced prostate cancer, but did not
have information on the stage or grade of prostate cancers
diagnosed in the present study. However, we were able to ascertain
fatal prostate cancers, which would reasonably reflect advanced
disease.
In conclusion, this study does not support the biologically
plausible hypothesis that a high calcium intake increases prostate
cancer risk. Further studies should include other populations, such
as Blacks, in whom prostate cancer rates are higher (Hayes et al,
1999; Gronberg, 2003), to extend the generalisability of the present
findings.
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